IP Library › Assignment 039637/0925
Patent Assignment
Reel/Frame 039637/0925

Change of Name

Recorded: 2016-08-09 Pages: 5
Assignor
ENVIVO PHARMACEUTICALS, INC.
Executed: 2014-04-02
Assignee
FORUM PHARMACEUTICALS, INC.
225 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Property (1)
Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
Application: 15/232,707 →
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 9, 2016
From: CHESWORTH, RICHARD; SHAPIRO, GIDEON; KOENIG, GERHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 039388/0447 →